Skin Cancer Clinical Trials

Currently Enrolling

Phoenix, Arizona Clinical Trials:
  • Biofrontera Protocol ALA-BCC-CT013: Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT) (Clinical Trial Conducted in Phoenix, Arizona – 7th Street Location)  |  Learn More »  |  Request to Join This Study »

  • DermTech Protocol 14-03: Harvesting of RNA-Containing Biological Material From Skin Cancer, Skin Cancer Precursors and Other Dermatological Conditions Via DermTech’s Non-Invasive Adhesive Skin Sample Collection Kit (Clinical Trial Conducted in Phoenix, Arizona – 7th Street Location)  |  Established Patients Only

  • CASTLE Biosciences Protocol CBI_2019_cSCC_PVS_001: Prospective Development and Validation of a Gene Expression Assay to Predict the Risk of Recurrence Disease in Cutaneous Squamous Cell Carcinoma (Clinical Trial Conducted in Phoenix, Arizona – 7th Street Location)  |  Established Patients Only

  • CASTLE Biosciences Protocol CBI_2020_COCM_001: Outcomes of Cutaneous Melanoma Patients Clinically Tested DecisionDx®-Melanoma (CONNECTION) (Clinical Trial Conducted in Phoenix, Arizona – 7th Street Location)  |  Established Patients Only

 

Active / Not Enrolling

Phoenix, Arizona Clinical Trials:
  • Vitamin D as a Nutritional Neoadjuvant during Photodynamic Therapy of Basal Cell Carcinoma in Basal Cell Nevus Syndrome. (Clinical Trial Conducted in Phoenix, Arizona – 7th Street Location) | Learn More »  |  No Longer Enrolling

 

View Other Clinical Trials